ChemotherapyFDA-approvedFirst-line

5-Fluorouracil

How it works

Inhibits thymidylate synthase, disrupting DNA synthesis and cell division in rapidly growing cancer cells.

Cancer types

Efficacy

Studies show that 5-fluorouracil can improve overall survival in patients with metastatic colorectal cancer, with median survival rates of approximately 12-14 months.

Side effects

Moderate

Side effects can be significant and may require dose adjustments or supportive medication, but the treatment is usually continued.

Evidence from research

StudyCancer typeStageEfficacy
New Delivery System Boosts Effectiveness of Cancer TreatmentColorectal Cancerlab-studyThe 5-FU/chitosan/β-cyclodextrin formulation showed an IC of 16.5 µM, compared with 42.5 µM for free 5-FU and 27.5 µM for the binary 5-FU/β-cyclodextrin complex.Source →
Testing a New Therapy for Advanced Colorectal CancerColorectal Cancerphase-1—Source →
Combining Baicalin and 5-Fluorouracil May Improve Colorectal Cancer TreatmentColorectal Cancerlab-study—Source →
Fibroblasts in Tumors May Contribute to Chemotherapy ResistanceColorectal Cancerlab-study—Source →
Curcumin Enhances Effectiveness of Colorectal Cancer TreatmentColorectal Cancerlab-study—Source →
Researchers Identify 5-Gene Model to Predict 5-Fluorouracil Resistance in Colorectal CancerColorectal Cancerlab-study—Source →
Combining Quercetin and 5-Fluorouracil May Help Treat Aggressive Breast CancerBreast Cancerlab-studyThe combination of 50 µM of QC and 25 nM of 5-FU reduced viability by 75% and migration by 87.8%.Source →
Enhanced Cancer Treatment with Cholesterol-Modified NanocarriersColorectal Cancerlab-studyThe 1:3 complex reduced metabolic activity and cell viability by over 60%.Source →
Combining Chemotherapy Drugs May Help Target Cancer Stem Cells in Aggressive Breast CancerBreast Cancerlab-study—Source →
Understanding Chemoresistance in Colorectal CancerColorectal Cancerlab-study—Source →
Researchers Identify Metabolites that Enhance 5-Fluorouracil Efficacy in Colon CancerColorectal Cancerlab-study—Source →
Chemokine Linked to Resistance in Colorectal Cancer TreatmentColorectal Cancerlab-study—Source →
Targeted Cancer Treatment Combines Chemotherapy with Gut Microbiota RegulationColorectal Canceranimal-studyFLSK significantly extends the survival period of mice.Source →
Combining 5-Fluorouracil and Menadione May Help Treat Colorectal CancerColorectal Cancerlab-study—Source →
METTL3 and TRAP1 play a key role in how well colorectal cancer responds to a common chemotherapy drugColorectal Cancerlab-study—Source →
Lab Study Finds New Way to Enhance Cancer TreatmentColorectal Cancerlab-study—Source →
Cancer Treatment Raises Triglyceride Levels in PatientColorectal Cancerobservational—Source →
New Compounds Show Promise Against Colon CancerColorectal Cancerlab-studyThe compound SI1/22 and the combination of SI1/22 with 5-FU had greater potency than 5-FU.Source →
Thymoquinone Enhances Effectiveness of Cancer Treatment in Lab ExperimentsColorectal Cancerlab-study—Source →
Corilagin Enhances Effectiveness of Cancer TreatmentColorectal Cancerlab-study—Source →
Hemodialysis Effectiveness in Removing 5-Fluorouracil and Its MetabolitesColorectal Cancerlab-studyThe removal rates of 5-fluorouracil and its metabolite FBAL were 81.2±23.2% and 96.1±8.6%, respectively.Source →
Bletilla striata polysaccharide may reduce side effects of chemotherapyColorectal Canceranimal-study—Source →
Monitoring Chemotherapy Doses Helps Patients Receive Optimal TreatmentColorectal Cancerobservational—Source →
New Nanoparticles Deliver Cancer Medicine More EffectivelyColorectal Cancerlab-study5FU-RuNPs showed a 2.61-fold higher cytotoxic effect compared to free 5FU.Source →
New Compound May Help Overcome Chemoresistance in Colorectal CancerColorectal Canceranimal-study—Source →
Combining Natural Compounds and 5-Fluorouracil to Fight Colorectal CancerColorectal Cancerlab-study—Source →
MicroRNA-19b Linked to Chemotherapy Resistance in Rectal CancerColorectal Cancerlab-studymiR-19b overexpression significantly anticipates patient recurrence (p = 0.002)Source →
Circular RNA Linked to Chemoresistance in Colorectal CancerColorectal Cancerlab-study—Source →
New Nanoparticle Delivers Cancer Drug More SafelyColorectal Cancerlab-study—Source →
Radiation May Help Overcome Chemoresistance in Pancreatic CancerPancreatic Cancerlab-studyFU-R cells showed a 2.7-fold increase of the half maximal inhibitory concentration compared to FU-S parental cells.Source →
New Oral Formulation for Colorectal Cancer TreatmentColorectal Cancerlab-study—Source →
Researchers Enhance Cancer Treatment with New Delivery SystemColorectal Cancerlab-studyThe combination therapy achieved a tumor inhibition rate of 56.9%.Source →
New Drug Delivery System Shows Promise for Pancreatic Cancer TreatmentPancreatic Cancerlab-study—Source →
Combining Curcumin with 5-Fluorouracil May Enhance Colorectal Cancer TreatmentColorectal Cancerlab-study—Source →
Gold Nanoparticles Deliver Cancer Medicine to ColonColorectal Cancerlab-studyThe optimized particles demonstrated 75.7% drug release and 8.9% cytotoxicity against colon cancer cell lines.Source →
Fish Oil May Help Overcome Chemotherapy Resistance in Colon CancerColorectal Canceranimal-study—Source →
5-Fluorouracil and Nutrient Starvation May Trigger Inflammation in Pancreatic CancerPancreatic Cancerlab-study—Source →

This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.